About
Who We Are
Executive Management
Board of Directors
Scientific Advisors
Therapeutic Potential
Pipeline
Publications
Investors
Overview
News & Events
Company Info
Presentations
Financial Info
Stock Data
SEC Filings
Governance
Email Alerts
Media
Videos
Articles and Presentations
Contact
Artelo Biosciences
About
Who We Are
Executive Management
Board of Directors
Scientific Advisors
Therapeutic Potential
Pipeline
Publications
Investors
Overview
News & Events
Company Info
Presentations
Financial Info
Stock Data
SEC Filings
Governance
Email Alerts
Media
Videos
Articles and Presentations
Contact
All SEC Filings
Investors
Investors
Overview
News & Events
Overview
Press Releases
Media
IR Calendar
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Presentations
Financial Info
Overview
Financial Results
Stock Data
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Email Alerts
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Filing Type:
View All
10-K
10-K/A
10-Q
10-Q/A
3
4
424B3
424B4
424B5
8-A12B
8-K
8-K/A
CERT
CORRESP
CT ORDER
D
DEF 14A
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2021
2020
2019
2018
2017
2016
2015
2014
Date
Form
Description
PDF
XBRL
Pages
01/21/21
EFFECT
Notice of Effectiveness
1
01/21/21
EFFECT
Notice of Effectiveness
1
01/21/21
POS AM
Post-effective amendment to a registration statement that is not immediately effective upon filing
Documents
EX-23.1
11
01/15/21
POS AM
Post-effective amendment to a registration statement that is not immediately effective upon filing
Documents
EX-23.1
11
01/15/21
POS AM
Post-effective amendment to a registration statement that is not immediately effective upon filing
Documents
EX-23.1
11
01/15/21
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
3
01/14/21
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Documents
EX-31.1
EX-32.1
53
01/13/21
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
9
12/16/20
S-8
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Documents
EX-4.1
EX-5.1
EX-23.1
EX-99.1
36
12/07/20
4
Statement of changes in beneficial ownership of securities
2
Previous
1
2
3
4
5
6
7
8
9
10
…23
Next
Email Alerts
Presentation
Contacts
RSS News Feed